These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32932755)

  • 1. A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth.
    Molina-Peña R; Tudon-Martinez JC; Aquines-Gutiérrez O
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapy against cancer stem cells.
    Yang T; Rycaj K
    Oncol Lett; 2015 Jul; 10(1):27-33. PubMed ID: 26170972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple mathematical model based on the cancer stem cell hypothesis suggests kinetic commonalities in solid tumor growth.
    Molina-Peña R; Álvarez MM
    PLoS One; 2012; 7(2):e26233. PubMed ID: 22363395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment.
    Wang T; Narayanaswamy R; Ren H; Torchilin VP
    Cancer Biol Ther; 2016 Jun; 17(6):698-707. PubMed ID: 27259361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for cancer stem cell elimination: insights from mathematical modeling.
    Vainstein V; Kirnasovsky OU; Kogan Y; Agur Z
    J Theor Biol; 2012 Apr; 298():32-41. PubMed ID: 22210402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
    Machida K
    Hepatol Int; 2017 Mar; 11(2):143-147. PubMed ID: 27990610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer.
    Shibata M; Hoque MO
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells.
    Mohan A; Raj Rajan R; Mohan G; Kollenchery Puthenveettil P; Maliekal TT
    Front Cell Dev Biol; 2021; 9():668851. PubMed ID: 34150761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Cancer Stem Cells: Therapeutic and diagnostic strategies by the virtue of nanoparticles.
    Shrestha S; Banstola A; Jeong JH; Seo JH; Yook S
    J Control Release; 2022 Aug; 348():518-536. PubMed ID: 35709876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapies targeting cancer stem cells: Current trends and future challenges.
    Dragu DL; Necula LG; Bleotu C; Diaconu CC; Chivu-Economescu M
    World J Stem Cells; 2015 Oct; 7(9):1185-201. PubMed ID: 26516409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer stem cells: opportunities and challenges.
    Chhabra R
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.
    Marcucci F; Ghezzi P; Rumio C
    Mol Cancer; 2017 Jan; 16(1):3. PubMed ID: 28137290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer Features.
    Enderling H; Hlatky L; Hahnfeldt P
    Front Oncol; 2013; 3():76. PubMed ID: 23596563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?
    Santamaria S; Delgado M; Kremer L; Garcia-Sanz JA
    Front Immunol; 2017; 8():1509. PubMed ID: 29170667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.